Cart
Products
<< Back to Chromatin Club Home Page
Boston Epigenetic Society (BES)
The Boston Epigenetic Society has been founded to:
- Promote epigenetics and epitranscriptomics
- Foster research connections between academics and industry epigenetics scientists
- Help promote new methods
- Create a support system for experimental epigenetics research
The Society brings together both academic and industry partners all sharing a passion for epigenetics. Founding members represent the following institutions and companies: Accent Therapeutics, Alkermes, Astellas Pharma, AstraZeneca, Constellation Pharmaceuticals, Ring Therapeutics, Sanofi, Beth Israel Deaconess Medical School, Broad Institute, Harvard Medical School, Harvard University, Massachusetts General Hospital, University of Massachusetts Medical School
For more information about the organization and events, please visit and join the BES LinkedIn Group.
Attendance is free of charge, but registration is required.
Upcoming Event Details
Date: May 16, 2024
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Featured Presenter:
- Genevieve Fourel, Ph.D. – Research Director, INSERM, Laboratory of Cell Biology and Modelling (LBMC), ENS Lyon
ProA and ProB Repeat Sequences Shape Genome Organization in Eukaryotes, and Enhancers Open Chromatin Domains
Previous Event Details
Date: March 21, 2024
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Featured Presenter:
- Rong Fan Ph.D. – Professor, Dept. of Biomedical Engineering, Yale Univ
Spatial Epigenome Sequencing for Mapping Tissue Function, Aging and Diseases
Date: February 29, 2024
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Topic: Unlocking the Regulatory Genome: Pioneering RNA-Guided Therapeutics for Cell-State Modulation in Disease Pathogenesis
Featured Presenter:
- Samir Ounzain, Ph.D. – CEO and Scientific Co-Founder, HAYA Therapeutics
Date: January 31, 2024
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Topic: TBA
Featured Presenter:
- Cigall Kadoch, Ph.D. – Associate Professor of Pediatric Oncology, Dana-Farber Cancer Center and Harvard Medical School; Scientific Founder, Foghorn Therapeutics
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Disease
Date: November 9, 2023
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Topic: DNA: What is it Trying to Tell Us?
Featured Presenter:
- Sir Shankar Balasubramanian, Ph.D. – Professor of Medicinal Chemistry, University of Cambridge
Date: September 21, 2023
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Topic: Biology of NSD2 and Clinical Opportunities for KTX-1001, the First NSD2 Inhibitor to Enter the Clinic
Featured Presenters:
- Terry Connolly, Ph.D. – CEO, K36 Therapeutics
- Or Gozani, M.D., Ph.D. – Dr. Morris Herzstein Professor of Biology, Stanford University
Date: May 18, 2023
Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)
Featured Presenter:
- John Rinn, Ph.D. – Leslie Orgel Professor of RNA Science at University of Colorado, Boulder
The Role of lncRNAs in Transcriptional Regulation
